Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The FDA should be banging down Humanigen‘s door to hand them an EUA. The S-1 revisions shows the phase II, high patient success rate even in patients with underlying conditions such as diabetes and lung disease - discharged so quickly… The only upstream GM-CSF regulator in trials. This is literally a race to save lives. There has been more flexibility on less successful studies. $HGEN
$4.50 range looks pretty heavily rejected after the first 15 minutes. Hopefully it holds up. I’m not the best chartist, especially when there low volume like this.
The evidence is clear as day. We are owed an EUA. It’s past due!!!
Lenzilumab was granted emergency single use Investigational New Drug Application (“IND”) authorization from the FDA (often referred to as compassionate use) to treat patients with COVID-19. On June 15, 2020, we announced that Mayo Clinic data derived from the compassionate use of lenzilumab in treatment of 12 patients hospitalized in the Mayo Clinic system was published by Mayo Clinic. Under applicable FDA rules, a patientcannot receive a compassionate use drug unless FDA has issued an individual patient emergency IND authorization, which the Mayo Clinic requested from FDA prior to each individual patient dosing of lenzilumab. Accordingly, there was no randomized control group in the Mayo Clinic program.We did not pre-select patients to receive lenzilumab through the compassionate use program and did not deny any requests for compassionate use.Mayo Clinic clinicians solely determined which patients for which they would request emergency IND authorization from the FDA.
Agreed! I’m already buckled up!
The difference is Uncle Sam is throwing billions at GILD. They placed their bet. HGEN can not be ignored much longer here.
It should but we need some phase 3 results from more patients. Our phase 2 was a small study with incredible results. Need more results ASAP! If we have a similar success rate you can bet this will move fast.
Nice! I’m going to do some more research today. I’m sure I will be buying. The info I quoted is from a trading buddy who emails me stuff like that about a dozen times a day. He’s usually on the money. I also shared this info with my brother-in-law who’s a pulmonologist at a medical center in a heavily hit Covid area. I will share any details. Good luck!
Caladrius Biosciences, CLBS
Adding this to the watchlist.
Quote:
I did some research on this company/stock over the weekend, and mentioned it to some friends early today. They have an interesting play on the pulmonary damage to vessels in COVID-19 compromised patients. This pulmonary damage is serious and long lasting, I will not cite the many reviews that describe this.
CLBS has a stem cell therapy in the works that focuses on CD34+ cell therapies. The data to support this cell type being a target of the virus is not clear to me, but seems reasonable based on other vessel growth from stem cells, but that is why one does the study. I bought some shares at market open this morning to keep me watching their progress. Mgmt has some good background to get it done. The stock got some attention today, and in after hours. There is evidence that these CD34+ progenitor cells are a target of the original SARS coronavirus, citation below. Here is the corporate presentation:
https://www.caladrius.com/investors/corporate-presentations/
Here are a couple slides from this nascent story:
Half mil. Volume in 4 minutes
If this technology can truly be implemented than it could possibly make gas powered vehicles obsolete. And what would that do to the battery market?
Ask keeps climbing. 3 cent open!!!
I’m in.
Not the best start for some this morning. Happy Monday.
FDA rejects CytoDyn's leronlimab application for HIV https://seekingalpha.com/news/3590460-fda-rejects-cytodyns-leronlimab-application-for-hiv
Zuma***. LOL
The Zumba-19 is the collaboration with Kite, correct?
She’s actually a good find. And I don’t mean that sexually. Lol. Click on her name, she has some other good articles.
Are you secretly Amy Murphy? Haha
MVM’s tweet is in the article. Lol!
Wow! I just left my office a little bit ago. Figured everything look pretty doll for the rest of the day.
Wasn’t there a bunch of press releases about a week and half ago about CYDY covid treatment being a scam or something? I’m not bashing. This is an honest question. I have not been following that company. Does that news correlates with their daily drop is pps over that same approx time?
Wow 4x average volume in half a day.
I guess the conference call was a bad idea.
The CY guys are about to tank
This is great info.
Venrock’s first 3 listed Holdings on this website:
AXSM - went from under $2 to $109
ECYT - went from $1 to $24
HGEN - story unfolding.
Well as you said yesterday, “it’s time to hold on to every share”. And I agreed and did not take any profit today either.
The fall below $5.50 was tough. I like to watch for the bounce off VWAP and hold above which didn’t happen. I wouldn’t call it sloppy. The MM has been controlling this since before the volume. You explain this better than me. I think there’s much more to come where this won’t be possible to occur.
This will not be life changing for me either but I have invested more in this one than any of my others trades before. We have great info, aligning stars and the obvious smart traders here (yourself included). I feel good about this one. Market-moving shock and success is coming.
There are no phony pumpers here. It is not needed to make a run with $HGEN!
AC11, welcome! There is tons of excitement here. And beyond that you have a handful of folks on this board that are more knowledgeable and experienced than I have found on any other iHub board. You will be well informed in short time. Get ready to make some money!
HGEN -- LENZILUMAB
NASDAQ approval momentarily
GILD/KITE collaboration study underway for treatment of relapsed B-cell lymphoma cancer patients. Awaiting feedback on preliminary data - momentarily.
Phase 3 clinical trials underway for Covid-19 therapeutic treatments, preliminary data - momentarily.
The ONLY Covid-19 play that has their sh*t together!!
No government funding is our blessing in disguise.
Moderna delay a snapshot of 'squabbles' with U.S. scientists over COVID-19 vaccine trials: Reuters
insert-text-here
Looks like it took 24 hours for the news to hit!
It’s almost scary what can happen here.
140k volume
15% pop
Less than 10 minutes
LOL!!!!!!
Amazing. It’s finally here. Look at that volume!
This is the most volume I seen squeak through before the open and it’s still one hour away. Today could get pretty crazy!
I’m aware but it gives a good timeline of events.
$PASO
Just found this on a tweet about 30 minutes ago. Looks pretty interesting. Just starting to dig. If anybody has info please share.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155954125
Hello PASO. Just found this about 30 minutes ago on a twitter post. Starting some DD. Looks like tons of info and action over the passed 6 months or so.
Can someone give me a rundown on what’s expected over the coming weeks? Like I said lots of info to dig into but certainly looks worth getting a starter tomorrow. Thank you and good luck!!
The set up reminds me of AXSM. I had a bunch of shares at the beginning of 2019 for $3. It’s shot up over $10 and I cashed out very excited. Later that year it climbed to $109! I still get sick sometimes.
Wow you can’t close better than this! Huge Huge Huge.
I'm gonna get me one of those fur coats when we break $15.91 (that's the price where my total account value will be double from HGEN)!!
It feels like the holidays, when all you’re friends swing by to have a drink and say hello. LOL.
Previous 30 minute candle broke 100k volume. Almost half daily avg. volume.
Ground floor. Going up? MVM is our liftman!